Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation of the Orexin 1 Receptor is a Critical Component of CO2-Mediated Anxiety and Hypertension but not Bradycardia
Philip L. Johnson, Brian C. Samuels, Stephanie D. Fitz, et al.
Neuropsychopharmacology (2012) Vol. 37, Iss. 8, pp. 1911-1922
Open Access | Times Cited: 98

Showing 26-50 of 98 citing articles:

Acid–base dysregulation and chemosensory mechanisms in panic disorder: a translational update
Lauren L. Vollmer, Jeffrey R. Strawn, Renu Sah
Translational Psychiatry (2015) Vol. 5, Iss. 5, pp. e572-e572
Open Access | Times Cited: 57
CO2 exposure as translational cross-species experimental model for panic
Nicole Leibold, Daniël van den Hove, Wolfgang Viechtbauer, et al.
Translational Psychiatry (2016) Vol. 6, Iss. 9, pp. e885-e885
Open Access | Times Cited: 55
Role of orexin type-1 receptors in paragiganto-coerulear modulation of opioid withdrawal and tolerance: A site specific focus
S. Mohammad Ahmadi‐Soleimani, Hossein Azizi, Heinrich S. Gompf, et al.
Neuropharmacology (2017) Vol. 126, pp. 25-37
Open Access | Times Cited: 54
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Erin J. Campbell, Nathan J. Marchant, Andrew J. Lawrence
Brain Research (2018) Vol. 1731, pp. 145902-145902
Closed Access | Times Cited: 50
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans
Giacomo Salvadore, Pascal Bonaventure, Anantha Shekhar, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus
Philip L. Johnson, Anantha Shekhar
Physiology & Behavior (2012) Vol. 107, Iss. 5, pp. 686-698
Open Access | Times Cited: 49
Differential actions of orexin receptors in brainstem cholinergic and monoaminergic neurons revealed by receptor knockouts: implications for orexinergic signaling in arousal and narcolepsy
Kristi A. Kohlmeier, Christopher J. Tyler, Mike Kalogiannis, et al.
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 46
Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation
Pascal Bonaventure, Christine Dugovic, Brock T. Shireman, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 42
Acute orexin antagonism selectively modulates anticipatory anxiety in humans: implications for addiction and anxiety
Stephanie M. Gorka, Kia J. Khorrami, Charles A. Manzler, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Evaluation of Low versus High Volume per Minute Displacement CO2 Methods of Euthanasia in the Induction and Duration of Panic-Associated Behavior and Physiology
Debra L. Hickman, Stephanie D. Fitz, Cristian Bernabe, et al.
Animals (2016) Vol. 6, Iss. 8, pp. 45-45
Open Access | Times Cited: 33
Pharmacotherapy in Generalized Anxiety Disorder: Novel Experimental Medicine Models and Emerging Drug Targets
David S. Baldwin, Ruihua Hou, Robert P. Gordon, et al.
CNS Drugs (2017) Vol. 31, Iss. 4, pp. 307-317
Open Access | Times Cited: 33
Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes
Michael G. Gottschalk, Jan Richter, Christiane Ziegler, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Novel investigational therapeutics for panic disorder
Giampaolo Perna, Koen Schruers, Alessandra Alciati, et al.
Expert Opinion on Investigational Drugs (2014) Vol. 24, Iss. 4, pp. 491-505
Closed Access | Times Cited: 34
The brain acid–base homeostasis and serotonin: A perspective on the use of carbon dioxide as human and rodent experimental model of panic
Nicole Leibold, Daniël van den Hove, Gabriel Esquivel, et al.
Progress in Neurobiology (2015) Vol. 129, pp. 58-78
Closed Access | Times Cited: 31
Enhanced non-eupneic breathing following hypoxic, hypercapnic or hypoxic–hypercapnic gas challenges in conscious mice
Paulina M. Getsy, J A Davis, Gregory A. Coffee, et al.
Respiratory Physiology & Neurobiology (2014) Vol. 204, pp. 147-159
Open Access | Times Cited: 31
Multiple-dose clinical pharmacology of the selective orexin-1 receptor antagonist ACT-539313
Priska Kaufmann, Marion Anliker‐Ort, Georg Golor, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 108, pp. 110166-110166
Closed Access | Times Cited: 24
Orexin 2 receptor in the nucleus accumbens is critical for the modulation of acute stress-induced anxiety
Bin Li, Leilei Chang, Xiaochun Peng
Psychoneuroendocrinology (2021) Vol. 131, pp. 105317-105317
Closed Access | Times Cited: 22
Respiratory manifestations of panic disorder in animals and humans: A unique opportunity to understand how supramedullary structures regulate breathing
Richard Kinkead, Luana Tenorio, Guy Drolet, et al.
Respiratory Physiology & Neurobiology (2014) Vol. 204, pp. 3-13
Closed Access | Times Cited: 29
Orexin neuropeptides contribute to the development and persistence of generalized avoidance behavior in the rat
Daniele Viviani, Patrizia Haegler, François Jenck, et al.
Psychopharmacology (2014) Vol. 232, Iss. 8, pp. 1383-1393
Closed Access | Times Cited: 28
Differential behavioral sensitivity to carbon dioxide (CO2) inhalation in rats
A. Scott Winter, Rebecca Ahlbrand, Devanshi Naik, et al.
Neuroscience (2017) Vol. 346, pp. 423-433
Open Access | Times Cited: 27
Predicting extinction phenotype to optimize fear reduction
Marie‐H. Monfils, Hongjoo J. Lee, Nicole E. Keller, et al.
Psychopharmacology (2018) Vol. 236, Iss. 1, pp. 99-110
Open Access | Times Cited: 24
First‐in‐human study with ACT‐539313, a novel selective orexin‐1 receptor antagonist
Priska Kaufmann, Marion Anliker‐Ort, Georg Golor, et al.
British Journal of Clinical Pharmacology (2020) Vol. 86, Iss. 7, pp. 1377-1386
Open Access | Times Cited: 23
Understanding rat emotional responses to CO2
Lucía Améndola, Daniel M. Weary
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 23
Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety
Wojciech Ziemichód, Antonina Kurowska, Karolina Grabowska, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3575-3575
Open Access | Times Cited: 7

Scroll to top